Relay Therapeutics
RLAY
17.95
-0.79
-4.22%
Relay Therapeutics
US · RLAY
#2273 by market cap
Listed 2020
17.95
-0.79
-4.22%
Live - 5344 symbols - heartbeat 67s ago
· 2026-10-08 09:16
Pre-market
17.99
+0.22%
After-hours
17.95
0.00%
Overnight
17.95
0.00%
- Market cap
- 3.93B
- P/E (TTM)i
- -11.51
- P/Bi
- 4.42
- EPSi
- -1.61
- Div yieldi
- 0.00%
- 52W posi
- 78%
Reader sentiment
Are you bullish or bearish on RLAY?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
27.63 +53.9%
Price target rangecurrent 17.95
Low20.00
Avg27.63
High31.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-27 | JonesTrading | -- | BUY | 20.00 |
| 2026-09-22 | JonesTrading | -- | BUY | 20.00 |
| 2026-08-21 | H.C. Wainwright | -- | BUY | 29.00 |
| 2026-08-20 | H.C. Wainwright | -- | BUY | 29.00 |
| 2026-08-14 | J.P. Morgan | -- | BUY | 31.00 |
| 2026-08-10 | Citizens JMP | -- | BUY | 26.00 |
| 2026-08-07 | JonesTrading | -- | BUY | 20.00 |
| 2026-08-07 | BofA Securities | -- | BUY | 25.00 |
| 2026-08-07 | Barclays | -- | BUY | 30.00 |
| 2026-08-06 | TD Cowen | -- | BUY | -- |
| 2026-08-06 | CCORF | -- | BUY | 29.00 |
| 2026-08-03 | J.P. Morgan | -- | BUY | -- |
| 2026-07-20 | Goldman Sachs | -- | BUY | 31.00 |
| 2026-07-16 | CCORF | -- | BUY | 29.00 |
| 2026-07-08 | J.P. Morgan | -- | BUY | 28.00 |
| 2026-06-18 | TD Cowen | -- | BUY | -- |
| 2026-06-02 | TD Cowen | -- | BUY | -- |
| 2026-06-02 | JonesTrading | -- | BUY | 20.00 |
| 2026-06-02 | BofA Securities | -- | BUY | 21.00 |
| 2026-06-02 | Goldman Sachs | -- | BUY | 22.00 |
| 2026-05-26 | H.C. Wainwright | -- | BUY | 28.00 |
| 2026-05-25 | Guggenheim | -- | BUY | 26.00 |
| 2026-05-20 | Citizens JMP | -- | BUY | 21.00 |
| 2026-05-20 | Barclays | -- | BUY | 27.00 |
| 2026-05-19 | TD Cowen | -- | BUY | -- |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
2
■ Upgrades■ Downgrades
- 2 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: JonesTrading moved from Hold to Buy on 2026-05-19.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-19 | JonesTrading | HOLD → BUY | 20.00 |
| 2026-01-26 | Oppenheimer | HOLD → BUY | 14.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±18.11% | +0.10% (in line) |
| 2026/Q1 | 2026-05-05 | After close | ±16.73% | -0.62% (in line) |
| 2025/Q4 | 2026-02-26 | After close | -- | +12.01% |
| 2025/Q3 | 2025-11-06 | After close | ±34.07% | -7.35% (in line) |
| 2025/Q2 | 2025-08-07 | After close | ±30.09% | -7.74% (in line) |
| 2025/Q1 | 2025-05-05 | After close | ±28.31% | -5.12% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±61.33% | -13.33% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±25.28% | -1.76% (in line) |
| 2024/Q2 | 2024-08-06 | After close | ±25.59% | -7.93% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±27.36% | -0.57% (in line) |
| 2023/Q4 | 2024-02-22 | After close | ±22.23% | -5.39% (in line) |
| 2023/Q3 | 2023-11-02 | After close | ±25.68% | +1.62% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 09:16:24 · For reference only, not investment advice and not tailored to your situation.